130 related articles for article (PubMed ID: 9259253)
1. A longitudinal study of pulmonary function in Danish patients with systemic sclerosis.
Jacobsen S; Halberg P; Ullman S; Høier-Madsen M; Petersen J; Mortensen J; Wiik A
Clin Rheumatol; 1997 Jun; 16(4):384-90. PubMed ID: 9259253
[TBL] [Abstract][Full Text] [Related]
2. Increase of pulmonary diffusing capacity in systemic sclerosis.
Dujić Z; Eterović D; Tocilj J; Andjelinović D
Br J Rheumatol; 1994 May; 33(5):437-41. PubMed ID: 8173847
[TBL] [Abstract][Full Text] [Related]
3. Isolated DLco/VA reduction in systemic sclerosis patients: a new patient subset?
Corzo P; Pros A; Martinez-Llorens J; Molina L; Ling SF; Balcells E
Clin Rheumatol; 2018 Dec; 37(12):3365-3371. PubMed ID: 30368639
[TBL] [Abstract][Full Text] [Related]
4. Isolated diffusing capacity reduction in systemic sclerosis.
Steen VD; Graham G; Conte C; Owens G; Medsger TA
Arthritis Rheum; 1992 Jul; 35(7):765-70. PubMed ID: 1622414
[TBL] [Abstract][Full Text] [Related]
5. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.
Hoffmann-Vold AM; Aaløkken TM; Lund MB; Garen T; Midtvedt Ø; Brunborg C; Gran JT; Molberg Ø
Arthritis Rheumatol; 2015 May; 67(8):2205-12. PubMed ID: 25916462
[TBL] [Abstract][Full Text] [Related]
7. Long-term N-acetylcysteine therapy in systemic sclerosis interstitial lung disease: a retrospective study.
Rosato E; Rossi C; Molinaro I; Giovannetti A; Pisarri S; Salsano F
Int J Immunopathol Pharmacol; 2011; 24(3):727-33. PubMed ID: 21978705
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline.
Colaci M; Giuggioli D; Sebastiani M; Manfredi A; Lumetti F; Luppi F; Cerri S; Ferri C
Reumatismo; 2015 Dec; 67(4):149-55. PubMed ID: 27215180
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary function in Thai patients with systemic sclerosis; a single center 6-year retrospective study.
Pirompanich P; Sathitakorn O; Sakulvorakitti T
F1000Res; 2024; 13():296. PubMed ID: 38835937
[TBL] [Abstract][Full Text] [Related]
11. Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. A longitudinal analysis.
Tashkin DP; Clements PJ; Wright RS; Gong H; Simmons MS; Lachenbruch PA; Furst DE
Chest; 1994 Feb; 105(2):489-95. PubMed ID: 8306752
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.
Steen VD; Lucas M; Fertig N; Medsger TA
J Rheumatol; 2007 Nov; 34(11):2230-5. PubMed ID: 17937469
[TBL] [Abstract][Full Text] [Related]
13. Severity and features of frailty in systemic sclerosis-associated interstitial lung disease.
Guler SA; Kwan JM; Winstone TA; Milne KM; Dunne JV; Wilcox PG; Ryerson CJ
Respir Med; 2017 Aug; 129():1-7. PubMed ID: 28732817
[TBL] [Abstract][Full Text] [Related]
14. Static lung compliance as an index of early pulmonary disease in systemic sclerosis.
Sud A; Gupta D; Wanchu A; Jindal SK; Bambery P
Clin Rheumatol; 2001; 20(3):177-80. PubMed ID: 11434468
[TBL] [Abstract][Full Text] [Related]
15. Computer-Aided Tomographic Analysis of Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc). Correlation with Pulmonary Physiologic Tests and Patient-Centred Measures of Perceived Dyspnea and Functional Disability.
Salaffi F; Carotti M; Di Donato E; Di Carlo M; Ceccarelli L; Giuseppetti G
PLoS One; 2016; 11(3):e0149240. PubMed ID: 26930658
[TBL] [Abstract][Full Text] [Related]
16. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.
Guarnieri G; Zanatta E; Mason P; Scarpa MC; Pigatto E; Maestrelli P; Cozzi F
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S80-6. PubMed ID: 25897784
[TBL] [Abstract][Full Text] [Related]
17. [Lung involvement in systemic sclerosis].
Quadrelli S; Ciallella L; Catalán Pellet AC; Molinari L; Salvado A; Auad C; Spina JC
Medicina (B Aires); 2007; 67(5):429-35. PubMed ID: 18051224
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary functions in patients with progressive systemic sclerosis].
Takaya M; Ichikawa Y; Shimizu H; Moriuchi J; Uchiyama M; Arimori S
Ryumachi; 1994 Feb; 34(1):2-9. PubMed ID: 8146723
[TBL] [Abstract][Full Text] [Related]
19. Ventilation distribution and small airway function in patients with systemic sclerosis.
Silva BRA; Rufino R; Costa CH; Vilela VS; Levy RA; Lopes AJ
Rev Port Pneumol (2006); 2017; 23(3):132-138. PubMed ID: 28258938
[TBL] [Abstract][Full Text] [Related]
20. Retrospective studies in scleroderma: pulmonary findings and effect of potassium p-aminobenzoate on vital capacity.
Zarafonetis CJ; Dabich L; Devol EB; Skovronski JJ; Negri D; Yuan WY
Respiration; 1989; 56(1-2):22-33. PubMed ID: 2602668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
